Long-Term Response to Daily Low-Dose Subcutaneous Interferon-α2b in a Patient with Pretreated Metastatic Uveal Melanoma in the Liver and Lung

Publisher： Karger

E-ISSN： 1662-6575|1|1|5-10

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.1, Iss.1, 2008-11, pp. : 5-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Disease Stabilization in a Patient with Castration-Resistant Metastatic Prostate Cancer by the Addition of Lenalidomide to Low-Dose Dexamethasone and Celecoxib

By  

Oncology Research and Treatment, Vol. 35, Iss. 5, 2012-04 ,pp. : 279-282

Karger

Access to resources Recommend Favorite

Low-Dose, Long-Term, Intermittent Interferon-alpha-2b Therapy after Radical Treatment by Radiofrequency Ablation Delays Clinical Recurrence in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

By  

Intervirology, Vol. 48, Iss. 1, 2005-03 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Low-Dose Fulvestrant Maintained Long-Term Complete Remission after Poor Response to Previous Endocrine Therapies in a Patient with Advanced Breast Cancer

By  

Case Reports in Oncology, Vol. 3, Iss. 2, 2010-04 ,pp. : 131-136

Karger

Access to resources Recommend Favorite

Long‐term, low‐dose exposure to microcystin toxin does not increase the risk of liver tumor development or growth in mice

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 6, 2015-06 ,pp. : 683-692

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Adjuvant Interferon‐alpha Low‐dose Therapy in Melanoma Patients on Serum Inhibin B

By  

THE JOURNAL OF DERMATOLOGY, Vol. 27, Iss. 10, 2000-10 ,pp. : 639-642

John Wiley & Sons Inc

Access to resources Recommend Favorite